354(top 1%)
PR articles
39.5K(top 0.1%)
PR citations
84(top 0.1%)
PR h-index
93(top 0.1%)
h-index
437
documents
53.0K
doc citations
6.5K
citing journals
100
times ranked

Publications

379 peer-reviewed articles • 44,660 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Actigraphy validation in behavioral variant frontotemporal dementia
Sleep Medicine, 2025, 126, 178-184
0.91Citations (PDF)
2Randomized clinical trial (RCT): An overview
ENeurologicalSci, 2025, 38, 100547
0.84Citations (PDF)
3Assessment of clinical prognosis in autoimmune encephalitis: Girona score
Frontiers in Psychiatry, 2025, 16,
1.62Citations (PDF)
4Structural covariance network patterns linked to neuropsychiatric symptoms in biologically defined Alzheimer's disease: Insights from the mild behavioral impairment checklist
Journal of Alzheimer's Disease, 2025, 104, 338-350
1.65Citations (PDF)
5Contribution of fatigue experienced by Parkinson’s Disease patients on caregiver burden
Journal of Neurology, 2025, 272,
2.71Citations (PDF)
6Donanemab eligibility in early Alzheimer's disease: A real-world study
Journal of Alzheimer's Disease, 2025, 105, 745-750
1.613Citations (PDF)
7The Glymphatic System and Sleep Dysfunction in Parkinson’s Disease
Sleep Medicine Clinics, 2025, 20, 379-387
1.37Citations (PDF)
8Underdetection of neurocognitive disorders in Southern Italy: Evidence from the Salento region
journal of prevention of Alzheimer's disease, The, 2025, 12, 100295
3.64Citations (PDF)
9Resting-state EEG gamma power predicts immediate and delayed recall in healthy adults
Cognitive Neurodynamics, 2025, 19,
2.54Citations (PDF)
10Gamma (60 Hz) auditory stimulation improves intrusions but not recall and working memory in healthy adults
Behavioural Brain Research, 2024, 456, 114703
1.813Citations (PDF)
11Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia
Frontiers in Aging Neuroscience, 2024, 15,
2.72Citations (PDF)
12Nucleus Basalis of Meynert Degeneration Predicts Cognitive Decline in Corticobasal Syndrome
Biological Psychiatry, 2024, 95, 1048-1054
3.86Citations (PDF)
13Neurophysiological indices for split phenomena: correlation with age and sex and potential implications in amyotrophic lateral sclerosis
Frontiers in Neurology, 2024, 15,
1.65Citations (PDF)
14Explainable machine learning radiomics model for Primary Progressive Aphasia classification
Frontiers in Systems Neuroscience, 2024, 18,
2.06Citations (PDF)
15Sarcopenia in subjects with Alzheimer’s disease: prevalence and comparison of agreement between EGWSOP1, EGWSOP2, and FNIH criteria
BMC Geriatrics, 2024, 24,
2.13Citations (PDF)
16Deep Learning–based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy
Radiology: Artificial Intelligence, 2024, 6,
6.410Citations (PDF)
17Real-life management of patients with mild cognitive impairment: an Italian survey
Neurological Sciences, 2024, 45, 4279-4289
1.13Citations (PDF)
18Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease
Annals of Neurology, 2024, 96, 61-73
4.635Citations (PDF)
19Nerve conduction study on the split-hand plus index in Amyotrophic lateral sclerosis: correlations with lower motor neuron impairment
Neurological Sciences, 2024, 45, 4863-4870
1.10Citations (PDF)
20Accuracy of clinical diagnosis of behavioural variant frontotemporal dementia: a protocol for a systematic review and meta-analysis
BMJ Open, 2024, 14, e081935
1.20Citations (PDF)
21Consequences of age and education correction of cognitive screening tests – A simulation study of the MoCA test in Italy
Neurological Sciences, 2024, 45, 5697-5706
1.14Citations (PDF)
22An Atypical Case of Creutzfeldt-Jakob Syndrome Presenting with Cacosmia and Amyloid Positivity
Journal of Alzheimer's Disease Reports, 2024, 8, 1105-1110
1.60Citations (PDF)
23Treatment of Obstructive Sleep Apnea in patients with Alzheimer’s Disease: role of Continuous Positive Airway Pressure therapy
Current Treatment Options in Neurology, 2024, 26, 509-521
0.85Citations (PDF)
24Should Cognitive Screening Tests Be Corrected for Age and Education? Insights From a Causal Perspective
American Journal of Epidemiology, 2023, 192, 93-101
2.427Citations (PDF)
25Obituary Ettore Beghi
Clinical Neurology and Neurosurgery, 2023, 224, 107530
1.00Citations (PDF)
26Genotype-phenotype correlation in the spectrum of frontotemporal dementia-parkinsonian syndromes and advanced diagnostic approaches
Critical Reviews in Clinical Laboratory Sciences, 2023, 60, 171-188
3.63Citations (PDF)
27Split phenomena in amyotrophic lateral sclerosis: Current evidences, pathogenetic hypotheses and diagnostic implications
Frontiers in Neuroscience, 2023, 16,
2.014Citations (PDF)
28A Review on Music Interventions for Frontotemporal Aphasia and a Proposal for Alternative Treatments
Biomedicines, 2023, 11, 84
2.54Citations (PDF)
29The evolving role of quantitative actigraphy in clinical sleep medicine
Sleep Medicine Reviews, 2023, 68, 101762
5.469Citations (PDF)
30Cognitive and Neuropathophysiological Outcomes of Gamma-tACS in Dementia: A Systematic Review
Neuropsychology Review, 2023, 34, 338-361
2.851Citations (PDF)
31Split-elbow sign in the PRO-ACT and Southern Italy ALS cohorts: a potential marker of disease severity and lower motor neuron involvement?
Journal of Neurology, 2023, 270, 3204-3212
2.75Citations (PDF)
32The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach
Journal of Neurology, 2023, 270, 4868-4875
2.77Citations (PDF)
33Asymmetry of radiomics features in the white matter of patients with Primary Progressive Aphasia (P6-12.005)
Neurology, 2023, 100,
0.70Citations (PDF)
34Nucleus Basalis of Meynert degeneration predicts cognitive decline in Corticobasal Syndrome (P12-6.006)
Neurology, 2023, 100,
0.70Citations (PDF)
35Asymmetry of radiomics features in the white matter of patients with primary progressive aphasia
Frontiers in Aging Neuroscience, 2023, 15,
2.74Citations (PDF)
36Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders
Frontiers in Aging Neuroscience, 2023, 15,
2.718Citations (PDF)
37Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
Neurobiology of Disease, 2023, 185, 106237
3.523Citations (PDF)
38Cortical signature of depressive symptoms in frontotemporal dementia: A surface‐based analysis
Annals of Clinical and Translational Neurology, 2023, 10, 1704-1713
2.35Citations (PDF)
39Reperfusion strategies in stroke with medium-to-distal vessel occlusion: a prospective observational study
Neurological Sciences, 2023, 45, 1129-1134
1.112Citations (PDF)
40Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions
Journal of Neurology, 2023, 270, 5162-5170
2.74Citations (PDF)
41Grey-matter correlates of empathy in 4-Repeat Tauopathies
Npj Parkinson's Disease, 2023, 9,
4.44Citations (PDF)
42Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis
Brain, 2022, 145, 276-284
5.957Citations (PDF)
43FRONTotemporal dementia Incidence European Research Study—FRONTIERS: Rationale and design
Alzheimer's and Dementia, 2022, 18, 498-506
0.821Citations (PDF)
44The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy
Psychiatry Research, 2022, 308, 114346
2.48Citations (PDF)
45Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?
Frontiers in Psychiatry, 2022, 12,
1.611Citations (PDF)
46Imaging correlates of depression in progressive supranuclear palsy
Journal of Neurology, 2022, 269, 3522-3528
2.711Citations (PDF)
47Magnetic Resonance Parkinsonism Index Is Associated with REM Sleep Behavior Disorder in Parkinson’s Disease
Brain Sciences, 2022, 12, 202
1.84Citations (PDF)
48The Latin American Epidemiology Network for ALS (Laenals)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022, 23, 372-377
1.77Citations (PDF)
49Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers
Cells, 2022, 11, 581
3.328Citations (PDF)
50Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium
Alzheimer's and Dementia, 2022, 18, 1957-1968
0.817Citations (PDF)
51The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
Lancet Regional Health - Europe, The, 2022, 16, 100341
5.6270Citations (PDF)
52Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
JAMA Network Open, 2022, 5, e229588
5.240Citations (PDF)
53The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer's Disease Clinical Continuum
Frontiers in Neurology, 2022, 13,
1.643Citations (PDF)
54Decipher non‐canonical SPAST splicing mutations with the help of functional assays in patients affected by spastic paraplegia 4 ( SPG4 )
Clinical Genetics, 2022, 102, 155-156
1.55Citations (PDF)
55Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis
Journal of Cellular and Molecular Medicine, 2022, 26, 3608-3615
2.415Citations (PDF)
56Radiomics Model for Frontotemporal Dementia Diagnosis Using T1-Weighted MRI
Frontiers in Neuroscience, 2022, 16,
2.013Citations (PDF)
57A systematic review on resting state functional connectivity in patients with neurodegenerative disease and hallucinations
NeuroImage: Clinical, 2022, 35, 103112
2.214Citations (PDF)
58Clinical Conundrum: Dysphagia Associated with Sleep Disorders
Dysphagia, 2022, 38, 726-728
1.12Citations (PDF)
59The Role of Graph Theory in Evaluating Brain Network Alterations in Frontotemporal Dementia
Frontiers in Neurology, 2022, 13,
1.624Citations (PDF)
60Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease
Npj Parkinson's Disease, 2022, 8,
4.418Citations (PDF)
61The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas
Current Opinion in Neurology, 2022, 35, 678-685
2.420Citations (PDF)
62Deep networks for behavioral variant frontotemporal dementia identification from multiple acquisition sources
Computers in Biology and Medicine, 2022, 148, 105937
4.513Citations (PDF)
63Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires
BMC Geriatrics, 2022, 22,
2.110Citations (PDF)
64The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter study
Frontiers in Neuroscience, 2022, 16,
2.022Citations (PDF)
65Amyotrophic Lateral Sclerosis—The Complex Phenotype—From an Epidemiological Perspective: A Focus on Extrapyramidal and Non-Motor Features
Biomedicines, 2022, 10, 2537
2.512Citations (PDF)
66An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment
Frontiers in Aging Neuroscience, 2022, 14,
2.757Citations (PDF)
67Retinal Vascular Density on Optical Coherence Tomography Angiography and Age-Related Central and Peripheral Hearing Loss in a Southern Italian Older Population
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 2021, 76, 2169-2177
2.413Citations (PDF)
68Burden of Neurological Disorders Across the US From 1990-2017
JAMA Neurology, 2021, 78, 165
12.1581Citations (PDF)
69The Italian Version of the Test Your Memory (TYM-I): A Tool to Detect Mild Cognitive Impairment in the Clinical Setting
Frontiers in Psychology, 2021, 11,
1.66Citations (PDF)
70The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey
Frontiers in Aging Neuroscience, 2021, 12,
2.7113Citations (PDF)
71FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective
International Journal of Molecular Sciences, 2021, 22, 1605
3.2121Citations (PDF)
72The links between diabetes mellitus and amyotrophic lateral sclerosis
Neurological Sciences, 2021, 42, 1377-1387
1.129Citations (PDF)
73Brain Structural Covariance Networks in Behavioral Variant of Frontotemporal Dementia
Brain Sciences, 2021, 11, 192
1.816Citations (PDF)
74Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose–response meta-analysis
Journal of Neurology, 2021, 268, 2973-2984
2.728Citations (PDF)
75Exploring dementia and neuronal ceroid lipofuscinosis genes in 100 FTD-like patients from 6 towns and rural villages on the Adriatic Sea cost of Apulia
Scientific Reports, 2021, 11,
2.710Citations (PDF)
76Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown
Frontiers in Aging Neuroscience, 2021, 13,
2.757Citations (PDF)
77Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2021, 22, 478-485
1.711Citations (PDF)
78Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes
Biological Psychiatry, 2021, 89, 825-835
3.819Citations (PDF)
79Dietary Habits and Nutrient Intakes Are Associated to Age-Related Central Auditory Processing Disorder in a Cohort From Southern Italy
Frontiers in Aging Neuroscience, 2021, 13,
2.74Citations (PDF)
80Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis
Nature Medicine, 2021, 27, 1197-1204
22.6153Citations (PDF)
81Association Between Central and Peripheral Age-Related Hearing Loss and Different Frailty Phenotypes in an Older Population in Southern Italy
JAMA Otolaryngology - Head and Neck Surgery, 2021, 147, 561
2.545Citations (PDF)
82A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer’s Disease in a Large Italian Family
International Journal of Molecular Sciences, 2021, 22, 6215
3.26Citations (PDF)
83Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants
Frontiers in Genetics, 2021, 12,
1.68Citations (PDF)
84Hearing Function: Identification of New Candidate Genes Further Explaining the Complexity of This Sensory Ability
Genes, 2021, 12, 1228
1.88Citations (PDF)
85Reduction of Sniff Nasal Inspiratory Pressure (SNIP) as an Early Indicator of the Need of Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis
Brain Sciences, 2021, 11, 1091
1.85Citations (PDF)
86Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis
JAMA Neurology, 2021, 78, 1236
12.184Citations (PDF)
87The Role of Age on Beta-Amyloid1–42 Plasma Levels in Healthy Subjects
Frontiers in Aging Neuroscience, 2021, 13,
2.726Citations (PDF)
88Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides
Neuroscience and Biobehavioral Reviews, 2021, 127, 193-211
4.3211Citations (PDF)
89Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019
Journal of Neurology, 2021, 269, 2080-2098
2.742Citations (PDF)
90Stroke epidemiology and COVID-19 pandemic
Current Opinion in Neurology, 2021, 34, 3-10
2.423Citations (PDF)
91proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay
Frontiers in Aging Neuroscience, 2021, 13,
2.77Citations (PDF)
92Autism Spectrum Disorder and Prenatal or Early Life Exposure to Pesticides: A Short Review
International Journal of Environmental Research and Public Health, 2021, 18, 10991
2.026Citations (PDF)
93Altered structural brain networks in linguistic variants of frontotemporal dementia
Brain Imaging and Behavior, 2021, 16, 1113-1122
1.519Citations (PDF)
94Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Nature Genetics, 2021, 53, 1636-1648
14.1544Citations (PDF)
95Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR
Journal of Neurology, Neurosurgery and Psychiatry, 2020, 91, 33-39
4.230Citations (PDF)
96Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study
Journal of Neurology, Neurosurgery and Psychiatry, 2020, 91, 1001-1003
4.226Citations (PDF)
97Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy
Journal of Alzheimer's Disease, 2020, 76, 481-489
1.644Citations (PDF)
98Association between Structural Connectivity and Generalized Cognitive Spectrum in Alzheimer’s Disease
Brain Sciences, 2020, 10, 879
1.817Citations (PDF)
99Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia
Frontiers in Psychiatry, 2020, 11,
1.6197Citations (PDF)
100Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis
Scientific Reports, 2020, 10,
2.76Citations (PDF)
101Traditional Old Dietary Pattern of Castellana Grotte (Apulia) Is Associated with Healthy Outcomes
Nutrients, 2020, 12, 3097
3.211Citations (PDF)
102Plasma Inflammatory Cytokines Are Elevated in ALS
Frontiers in Neurology, 2020, 11,
1.685Citations (PDF)
103Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2020, 21, 542-548
1.752Citations (PDF)
104The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2020, 21, 337-343
1.73Citations (PDF)
105Focus on the heterogeneity of amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2020, 21, 485-495
1.765Citations (PDF)
106Relationship between Inflammatory Food Consumption and Age-Related Hearing Loss in a Prospective Observational Cohort: Results from the Salus in Apulia Study
Nutrients, 2020, 12, 426
3.249Citations (PDF)
107Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal
PLoS ONE, 2020, 15, e0231097
1.55Citations (PDF)
108Age‐Related Central Auditory Processing Disorder, MCI, and Dementia in an Older Population of Southern Italy
Otolaryngology - Head and Neck Surgery, 2020, 163, 348-355
1.650Citations (PDF)
109The Modified Five-Point Test (MFPT): normative data for a sample of Italian elderly
Neurological Sciences, 2020, 42, 2431-2440
1.18Citations (PDF)
110Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy
GeroScience, 2020, 43, 1003-1014
3.39Citations (PDF)
111Cerebrospinal Fluid TDP-43 is a Possible Predictor of Survival in Amyotrophic Lateral Sclerosis (4143)
Neurology, 2020, 94,
0.71Citations (PDF)
112Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study
Journal of Neurology, Neurosurgery and Psychiatry, 2019, 90, 11-19
4.234Citations (PDF)
113Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2019, 20, 176-185
1.744Citations (PDF)
114<p>Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: a case report</p>
Clinical Interventions in Aging, 2019, Volume 14, 727-733
4.15Citations (PDF)
115Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurology, 2019, 76, 1035
12.1746Citations (PDF)
116The Age-Related Central Auditory Processing Disorder: Silent Impairment of the Cognitive Ear
Frontiers in Neuroscience, 2019, 13,
2.0106Citations (PDF)
117Associations of Cognitive Function and Education Level With All-Cause Mortality in Adults on Hemodialysis: Findings From the COGNITIVE-HD Study
American Journal of Kidney Diseases, 2019, 74, 452-462
1.045Citations (PDF)
118Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients
Frontiers in Neuroscience, 2019, 13,
2.046Citations (PDF)
119Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
Expert Opinion on Pharmacotherapy, 2019, 20, 1091-1107
1.923Citations (PDF)
120Incidence of frontotemporal lobar degeneration in Italy
Neurology, 2019, 92,
0.750Citations (PDF)
121Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations
Journal of Neurology, Neurosurgery and Psychiatry, 2019, 90, 659-665
4.222Citations (PDF)
122Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia
Cortex, 2019, 117, 257-265
1.512Citations (PDF)
123Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid1–42 measurement
Clinica Chimica Acta, 2019, 493, 107-111
0.714Citations (PDF)
124Multicentre, population-based, case–control study of particulates, combustion products and amyotrophic lateral sclerosis risk
Journal of Neurology, Neurosurgery and Psychiatry, 2019, 90, 854-860
4.224Citations (PDF)
125Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 459-480
13.74,435Citations (PDF)
126Disease-modifying therapies for tauopathies: agents in the pipeline
Expert Review of Neurotherapeutics, 2019, 19, 397-408
2.320Citations (PDF)
127Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2019, 20, 404-412
1.78Citations (PDF)
128Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis
Annals of Neurology, 2019, 85, 470-481
4.6153Citations (PDF)
129Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications
International Journal of Geriatric Psychiatry, 2019, 34, 868-880
1.418Citations (PDF)
130A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Nature Reviews Neurology, 2019, 15, 73-88
18.3912Citations (PDF)
131Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life
Therapeutic Advances in Chronic Disease, 2019, 10,
1.5109Citations (PDF)
132Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies
Journal of Alzheimer's Disease, 2019, 67, 61-65
1.622Citations (PDF)
133Response to Letter to the Editor: “Plasma β-amyloid1–42 reference values”
Journal of the Neurological Sciences, 2019, 396, 123-124
1.20Citations (PDF)
134Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 88-106
13.72,141Citations (PDF)
135Clinical Swallowing Profile of Patients with Frontotemporal Dementia (P3.1-005)
Neurology, 2019, 92,
0.71Citations (PDF)
136Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, 2018, 89, 797-803
4.254Citations (PDF)
137Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention
Journal of Alzheimer's Disease, 2018, 62, 993-1012
1.6321Citations (PDF)
138Age-specific ALS incidence: a dose–response meta-analysis
European Journal of Epidemiology, 2018, 33, 621-634
3.488Citations (PDF)
139Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study
Nephrology Dialysis Transplantation, 2018, 33, 1197-1206
0.786Citations (PDF)
140Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder
Expert Opinion on Pharmacotherapy, 2018, 19, 823-842
1.952Citations (PDF)
141Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Neuron, 2018, 97, 1267-1288
8.2690Citations (PDF)
142An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities
Rejuvenation Research, 2018, 21, 3-14
0.943Citations (PDF)
143Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2018, 19, 118-125
1.732Citations (PDF)
144Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis
Journal of Neurology, Neurosurgery and Psychiatry, 2018, 89, 358-366
4.2160Citations (PDF)
145The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
Expert Opinion on Biological Therapy, 2018, 18, 25-35
1.942Citations (PDF)
146Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer’s disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer
International Journal of Social Psychiatry, 2018, 64, 26-36
1.410Citations (PDF)
147A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Brain, 2018, 141, 2895-2907
5.952Citations (PDF)
148Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2018, 17, 939-953
13.72,559Citations (PDF)
149BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
Expert Review of Neurotherapeutics, 2018, 18, 847-857
2.384Citations (PDF)
150Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review
Neuroscience and Biobehavioral Reviews, 2018, 95, 480-498
4.333Citations (PDF)
151Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2018, 17, 1083-1097
13.7243Citations (PDF)
152Referral bias in ALS epidemiological studies
PLoS ONE, 2018, 13, e0195821
1.533Citations (PDF)
153How complete is the information on preadmission psychotropic medications in inpatients with dementia? A comparison of hospital medical records with dispensing data
International Journal of Methods in Psychiatric Research, 2018, 27,
1.51Citations (PDF)
154Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study
Journal of Alzheimer's Disease, 2018, 65, 989-1000
1.647Citations (PDF)
155Plasma β-amyloid 1–42 reference values in cognitively normal subjects
Journal of the Neurological Sciences, 2018, 391, 120-126
1.226Citations (PDF)
156Clinical features and genetic characterization of two dizygotic twins with C9orf72 expansion
Neurobiology of Aging, 2018, 69, 293.e1-293.e8
2.41Citations (PDF)
157Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review
Journal of Alzheimer's Disease, 2018, 64, S229-S254
1.650Citations (PDF)
158Occupational exposures, biomarkers and neurodegenerative diseases
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia, 2018, 40, 162-166
0.00Citations (PDF)
159Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association
Journal of Alzheimer's Disease, 2017, 55, 973-979
1.627Citations (PDF)
160The changing picture of amyotrophic lateral sclerosis: lessons from European registers
Journal of Neurology, Neurosurgery and Psychiatry, 2017, 88, 557-563
4.2117Citations (PDF)
161Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor
Revue Neurologique, 2017, 173, 244-253
0.425Citations (PDF)
162Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease
Neurology, 2017, 88, 2321-2329
0.762Citations (PDF)
163Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline
Journal of Alzheimer's Disease, 2017, 59, 121-130
1.646Citations (PDF)
164Critical issues in ALS case-control studies: the case of the Euro-MOTOR study
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2017, 18, 411-418
1.719Citations (PDF)
165Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging
Journal of the American Medical Directors Association, 2017, 18, 89.e1-89.e8
1.5162Citations (PDF)
166Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions
Journal of the American Medical Directors Association, 2017, 18, 192.e1-192.e11
1.5361Citations (PDF)
167Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review
Journal of Alzheimer's Disease, 2017, 59, 815-849
1.6316Citations (PDF)
168Amyotrophic lateral sclerosis
Nature Reviews Disease Primers, 2017, 3,
37.81,384Citations (PDF)
169Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?
Expert Opinion on Drug Safety, 2017, 16, 1373-1385
1.611Citations (PDF)
170A case-control study of hormonal exposures as etiologic factors for ALS in women
Neurology, 2017, 89, 1283-1290
0.757Citations (PDF)
171Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort
Journal of Neurology, 2017, 264, 2224-2231
2.723Citations (PDF)
172Primary progressive aphasia: a review of neuropsychological tests for the assessment of speech and language disorders
Aphasiology, 2017, 31, 1359-1378
1.331Citations (PDF)
173Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Neurology, The, 2017, 16, 877-897
13.72,083Citations (PDF)
174Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry
Expert Review of Proteomics, 2017, 14, 809-824
1.647Citations (PDF)
175Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging
American Journal of Geriatric Psychiatry, 2017, 25, 1236-1248
1.6123Citations (PDF)
176Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
Expert Opinion on Drug Metabolism and Toxicology, 2017, 13, 259-277
2.514Citations (PDF)
177Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks
Frontiers in Neuroscience, 2017, 10,
2.065Citations (PDF)
178Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
BioMed Research International, 2016, 2016, 1-15
2.3171Citations (PDF)
179Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update
Parkinson's Disease, 2016, 2016, 1-27
0.319Citations (PDF)
180Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms
Frontiers in Neuroscience, 2016, 10,
2.099Citations (PDF)
181Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease
Parkinson's Disease, 2016, 2016, 1-14
0.325Citations (PDF)
182Warfarin Treatment and All‐Cause Mortality in Community‐Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study
Journal of the American Geriatrics Society, 2016, 64, 1416-1424
2.241Citations (PDF)
183Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders
Expert Review of Neurotherapeutics, 2016, 16, 1357-1369
2.311Citations (PDF)
184Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study
European Journal of Neurology, 2016, 23, 1117-1125
2.421Citations (PDF)
185A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy
Journal of Alzheimer's Disease, 2016, 53, 475-485
1.613Citations (PDF)
186TBK1 is associated with ALS and ALS-FTD in Sardinian patients
Neurobiology of Aging, 2016, 43, 180.e1-180.e5
2.441Citations (PDF)
187Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
Expert Opinion on Emerging Drugs, 2016, 21, 377-391
2.061Citations (PDF)
188Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy
Immunotherapy, 2016, 8, 1119-1134
1.286Citations (PDF)
189Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort study
BMC Pulmonary Medicine, 2016, 16,
1.544Citations (PDF)
190The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes
Expert Review of Precision Medicine and Drug Development, 2016, 1, 431-442
1.07Citations (PDF)
191Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Nature Genetics, 2016, 48, 1043-1048
14.1604Citations (PDF)
192Accuracy of clinical diagnosis of Parkinson disease
Neurology, 2016, 86, 566-576
0.7823Citations (PDF)
193Non-self-sufficiency as a primary outcome measure in ALS trials
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2016, 17, 77-84
1.710Citations (PDF)
194Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis: Table 1
Journal of Neurology, Neurosurgery and Psychiatry, 2016, 87, 678-679
4.218Citations (PDF)
195Factors predicting survival in ALS: a multicenter Italian study
Journal of Neurology, 2016, 264, 54-63
2.7123Citations (PDF)
196Prefrontal Activity and Connectivity with the Basal Ganglia during Performance of Complex Cognitive Tasks Is Associated with Apathy in Healthy Subjects
PLoS ONE, 2016, 11, e0165301
1.519Citations (PDF)
197The Role of Age on Beta-Amyloid1-42 Plasma Levels in Healthy Subjects (P5.174)
Neurology, 2016, 86,
0.70Citations (PDF)
198Pseudobulbar Affect (PBA) as a Predictor of Survival in ALS (P5.089)
Neurology, 2016, 86,
0.70Citations (PDF)
199The Questionable Role of GWA in Identification of Genetic Risk Factors for Alzheimer’s Disease (P5.165)
Neurology, 2016, 86,
0.70Citations (PDF)
200Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies: A Systematic Review and Meta-Analysis (P6.230)
Neurology, 2016, 86,
0.70Citations (PDF)
201Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype
Journal of Alzheimer's Disease, 2015, 47, 793-813
1.6121Citations (PDF)
202Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging
Journal of Alzheimer's Disease, 2015, 47, 889-899
1.664Citations (PDF)
203Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature
Toxins, 2015, 7, 3045-3056
2.545Citations (PDF)
204Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study
BMJ Open, 2015, 5, e007069
1.227Citations (PDF)
205COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis
BMJ Open, 2015, 5, e009328
1.212Citations (PDF)
206Epidemiology of age related hearing loss
Hearing, Balance and Communication, 2015, 13, 77-81
0.330Citations (PDF)
207Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke
Journal of the Neurological Sciences, 2015, 350, 1-6
1.253Citations (PDF)
208Age-related hearing impairment—a risk factor and frailty marker for dementia and AD
Nature Reviews Neurology, 2015, 11, 166-175
18.3237Citations (PDF)
209Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
Journal of Neurology, Neurosurgery and Psychiatry, 2015, 86, 879-886
4.240Citations (PDF)
210Amyotrophic Lateral Sclerosis: An Aging-Related Disease
Current Geriatrics Reports, 2015, 4, 142-153
0.924Citations (PDF)
211Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition
Rejuvenation Research, 2015, 18, 389-412
0.9138Citations (PDF)
212Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology
European Journal of Epidemiology, 2015, 30, 569-576
3.442Citations (PDF)
213Development of the Standards of Reporting of Neurological Disorders (STROND) checklist
Neurology, 2015, 85, 821-828
0.772Citations (PDF)
214Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial
Clinical Rehabilitation, 2015, 29, 50-58
1.844Citations (PDF)
215Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)
Journal of Neurology, 2015, 263, 316-321
2.721Citations (PDF)
216Stratification of ALS patients’ survival: a population-based study
Journal of Neurology, 2015, 263, 100-111
2.733Citations (PDF)
217Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin
European Journal of Epidemiology, 2015, 31, 229-245
3.4110Citations (PDF)
218A Novel Splice Site Mutation in GRN (p.A237fs [A>T]) in a Large Italian Family With FTD From The Apulia-FTD Registry (P2.160)
Neurology, 2015, 84,
0.71Citations (PDF)
219Accuracy of Clinical Diagnosis of Parkinson’s Disease: A Systematic Review and Bayesian Meta-Analysis (S36.001)
Neurology, 2015, 84,
0.70Citations (PDF)
220Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
Expert Review of Clinical Immunology, 2014, 10, 405-419
2.396Citations (PDF)
221Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques
Journal of the Neurological Sciences, 2014, 347, 39-43
1.262Citations (PDF)
222Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Current Opinion in Psychiatry, 2014, 27, 128-137
2.989Citations (PDF)
223Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Lancet, The, 2014, 384, 957-979
46.9679Citations (PDF)
224Physical activity and amyotrophic lateral sclerosis: A European population‐based case–control study
Annals of Neurology, 2014, 75, 708-716
4.690Citations (PDF)
225Extracorporeal Shock Wave Therapy for the Treatment of Poststroke Plantar-Flexor Muscles Spasticity: A Prospective Open-Label Study
Topics in Stroke Rehabilitation, 2014, 21, S17-S24
1.661Citations (PDF)
226Frontotemporal dementia and its subtypes: a genome-wide association study
Lancet Neurology, The, 2014, 13, 686-699
13.7392Citations (PDF)
227Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
Expert Opinion on Biological Therapy, 2014, 14, 1465-1476
1.968Citations (PDF)
228Prevention of Late-life Cognitive Disorders: Diet-Related Factors, Dietary Patterns, and Frailty Models
Current Nutrition Reports, 2014, 3, 110-129
4.69Citations (PDF)
229Long‐term survival in amyotrophic lateral sclerosis: A population‐based study
Annals of Neurology, 2014, 75, 287-297
4.6175Citations (PDF)
230Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
Lancet, The, 2014, 384, 766-781
46.910,243Citations (PDF)
231Early and severe autonomic failure: broadening the clinical phenotype of type-2 spinocerebellar ataxia. A case report
Journal of Neurology, 2014, 262, 224-225
2.73Citations (PDF)
232Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis
Journal of Neurology, 2014, 262, 593-603
2.765Citations (PDF)
233Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review
Journal of Nutrition, Health and Aging, 2014, 19, 313-328
2.4183Citations (PDF)
234Association Between Depression and Death in People With CKD: A Meta-analysis of Cohort Studies
American Journal of Kidney Diseases, 2013, 62, 493-505
1.0178Citations (PDF)
235Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies
Kidney International, 2013, 84, 179-191
4.2819Citations (PDF)
236Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination
European Journal of Epidemiology, 2013, 28, 433-444
3.444Citations (PDF)
237Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene
Neurobiology of Aging, 2013, 34, 1709.e3-1709.e5
2.422Citations (PDF)
238Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients
Parkinsonism and Related Disorders, 2013, 19, 980-985
2.093Citations (PDF)
239Amyotrophic lateral sclerosis in Catalonia: A population based study
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013, 14, 278-283
1.753Citations (PDF)
240Mitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013, 14, 261-266
1.715Citations (PDF)
241Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis
PLoS ONE, 2013, 8, e80748
1.590Citations (PDF)
242Gender Differences of Cortical Thickness in Amyotrophic Lateral Sclerosis (P06.137)
Neurology, 2013, 80,
0.71Citations (PDF)
243Elective Tracheostomy in Amyotrophic Lateral Sclerosis (ALS): The Prognostic Role of Sniff Nasal Ispiratory Pressure (SNIP) (P07.082)
Neurology, 2013, 80,
0.70Citations (PDF)
244Immunotherapy for Alzheimer‘s Disease: From Anti-β-Amyloid to Tau-Based Immunization Strategies
Immunotherapy, 2012, 4, 213-238
1.2126Citations (PDF)
245Dietary Flavonoids and Risk of Stroke in Women
Stroke, 2012, 43, 946-951
4.4187Citations (PDF)
246Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis
Neurology, 2012, 79, 2315-2320
0.784Citations (PDF)
247FUS mutations in sporadic amyotrophic lateral sclerosis: Clinical and genetic analysis
Neurobiology of Aging, 2012, 33, 837.e1-837.e5
2.436Citations (PDF)
248C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population
Neurobiology of Aging, 2012, 33, 1848.e15-1848.e20
2.478Citations (PDF)
249Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72
Brain, 2012, 135, 784-793
5.9200Citations (PDF)
250Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease
Ageing Research Reviews, 2012, 11, 87-103
9.065Citations (PDF)
251A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study
Orphanet Journal of Rare Diseases, 2012, 7,
1.8105Citations (PDF)
252Current Epidemiological Approaches to the Metabolic-Cognitive Syndrome
Journal of Alzheimer's Disease, 2012, 30, S31-S75
1.646Citations (PDF)
253Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?
International Journal of Geriatric Psychiatry, 2012, 27, 1218-1238
1.4103Citations (PDF)
254Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study
BMJ: British Medical Journal, 2011, 342, d198-d198
0.171Citations (PDF)
255Diet and Alzheimer’s disease risk factors or prevention: the current evidence
Expert Review of Neurotherapeutics, 2011, 11, 677-708
2.3267Citations (PDF)
256Sleep disorders and the natural history of Parkinson's disease: The contribution of epidemiological studies
Sleep Medicine Reviews, 2011, 15, 41-50
5.4103Citations (PDF)
257The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2011, 12, 1-10
2.1119Citations (PDF)
258A Population-based study of dementia in the oldest old: the Monzino 80-plus Study
BMC Neurology, 2011, 11,
1.327Citations (PDF)
259Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role
American Journal of Epidemiology, 2011, 174, 1002-1008
2.458Citations (PDF)
260Serum <emph type="ital">N</emph> -acetylaspartate Level in Amyotrophic Lateral Sclerosis
Archives of Neurology, 2011, 68, 1308
6.830Citations (PDF)
261Vitamin E Intake and Risk of Amyotrophic Lateral Sclerosis: A Pooled Analysis of Data From 5 Prospective Cohort Studies
American Journal of Epidemiology, 2011, 173, 595-602
2.4120Citations (PDF)
262Depression and Incident Stroke in Women
Stroke, 2011, 42, 2770-2775
4.4104Citations (PDF)
263Smoking and Risk of Amyotrophic Lateral Sclerosis
Archives of Neurology, 2011, 68,
6.8138Citations (PDF)
264Estimating risk for developing epilepsy
Neurology, 2011, 76, 23-27
0.7307Citations (PDF)
265Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging
Age, 2011, 34, 507-517
3.051Citations (PDF)
266Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging
Age, 2011, 35, 441-453
3.040Citations (PDF)
267Incidence of amyotrophic lateral sclerosis in Europe
Journal of Neurology, Neurosurgery and Psychiatry, 2010, 81, 385-390
4.2722Citations (PDF)
268Prognostication after cardiac arrest and hypothermia: A prospective study
Annals of Neurology, 2010, 67, 301-307
4.6557Citations (PDF)
269Refractory status epilepticus: A prospective observational study
Epilepsia, 2010, 51, 251-256
3.0368Citations (PDF)
270Natural history of upper motor neuron-dominant ALS
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2010, 11, 424-429
2.132Citations (PDF)
271Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study
BMC Neurology, 2010, 10,
1.354Citations (PDF)
272REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State
CNS Neuroscience and Therapeutics, 2010, 16, 272-284
3.572Citations (PDF)
273Amyotrophic lateral sclerosis, physical exercise, trauma and sports: Results of a population-based pilot case-control study
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2010, 11, 289-292
2.1113Citations (PDF)
274Homocysteine levels and amyotrophic lateral sclerosis: A possible link
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2010, 11, 140-147
2.157Citations (PDF)
275An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis
Journal of Neurology, 2010, 258, 238-243
2.752Citations (PDF)
276Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007
Environmental Health Perspectives, 2009, 117, 117-121
5.863Citations (PDF)
277Incidence and remaining lifetime risk of Parkinson disease in advanced age
Neurology, 2009, 72, 432-438
0.7267Citations (PDF)
278Use of antidepressants and the risk of Parkinson's disease: a prospective study
Journal of Neurology, Neurosurgery and Psychiatry, 2009, 80, 671-674
4.283Citations (PDF)
279Migraine frequency and risk of cardiovascular disease in women
Neurology, 2009, 73, 581-588
0.7159Citations (PDF)
280Reduced frequency of ALS in an ethnically mixed population
Neurology, 2009, 72, 1640-1645
0.7136Citations (PDF)
281Coffee Consumption and Risk of Stroke in Women
Circulation, 2009, 119, 1116-1123
13.1150Citations (PDF)
282Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia
Movement Disorders, 2009, 24, 1028-1033
3.259Citations (PDF)
283Prognostic factors in ALS: A critical review
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2009, 10, 310-323
2.11,063Citations (PDF)
284Status Epilepticus Severity Score (STESS)
Journal of Neurology, 2008, 255, 1561-1566
2.7408Citations (PDF)
285Amyotrophic lateral sclerosis and soccer: A different epidemiological approach strengthen the previous findings
Journal of the Neurological Sciences, 2008, 269, 187-188
1.212Citations (PDF)
286Predictors of long survival in amyotrophic lateral sclerosis: A population-based study
Journal of the Neurological Sciences, 2008, 268, 28-32
1.269Citations (PDF)
287Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2008, 9, 163-167
2.141Citations (PDF)
288Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Diabetes Care, 2008, 31, 2003-2005
5.6162Citations (PDF)
289Status Epilepticus Without an Underlying Cause and Risk of Death
Archives of Neurology, 2008, 65,
6.834Citations (PDF)
290Low Incidence of Stroke in Southern Italy
Stroke, 2008, 39, 2923-2928
4.423Citations (PDF)
291Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
Journal of Neurology, Neurosurgery and Psychiatry, 2008, 79, 6-11
4.2398Citations (PDF)
292Primary Prevention of Stroke by Healthy Lifestyle
Circulation, 2008, 118, 947-954
13.1438Citations (PDF)
293Dietary Iron Intake and Risk of Parkinson's Disease
American Journal of Epidemiology, 2008, 168, 1381-1388
2.492Citations (PDF)
294Parkinson disease and risk of mortality
Neurology, 2008, 70, 1423-1430
0.7129Citations (PDF)
295Adherence to a DASH-Style Diet and Risk of Coronary Heart Disease and Stroke in Women
Archives of Internal Medicine, 2008, 168, 713
8.11,427Citations (PDF)
296Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study
BMJ: British Medical Journal, 2008, 337, a2467-a2467
0.1159Citations (PDF)
297Migraine, vascular risk, and cardiovascular events in women: prospective cohort study
BMJ: British Medical Journal, 2008, 337, a636-a636
0.1230Citations (PDF)
298Myoclonic Encephalopathy after Exposure to Trichloroethylene
Industrial Health, 2008, 46, 635-637
2.74Citations (PDF)
299Gout and risk of Parkinson disease
Neurology, 2007, 69, 1696-1700
0.7177Citations (PDF)
300Incidence of ALS in Lombardy, Italy
Neurology, 2007, 68, 141-145
0.7133Citations (PDF)
301Efficacy of riluzole: Who are the patients enrolled in the studies?
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2007, 8, 124-125
2.13Citations (PDF)
302Status epilepticus
Neurology, 2007, 69, 255-260
0.7251Citations (PDF)
303Migraine and Risk of Cardiovascular Disease in Men
Archives of Internal Medicine, 2007, 167, 795
8.1214Citations (PDF)
304Erectile Function and Risk of Parkinson's Disease
American Journal of Epidemiology, 2007, 166, 1446-1450
2.4114Citations (PDF)
305Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes: The Nurses' Health Study
Diabetes Care, 2007, 30, 1730-1735
5.6201Citations (PDF)
306Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota
Neurology, 2007, 69, 73-78
0.743Citations (PDF)
307Progressive Supranuclear Palsy-like Parkinsonism Resulting from Occupational Exposure to Lead Sulphate Batteries
Journal of International Medical Research, 2007, 35, 159-163
1.010Citations (PDF)
308Amyotrophic lateral sclerosis: A global threat with a possible difference in risk across ethnicities
Neurology, 2007, 68, E17-E17
0.72Citations (PDF)
309A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease
Cancer Epidemiology Biomarkers and Prevention, 2007, 16, 1260-1265
0.6161Citations (PDF)
310Body Mass Index and Risk of Parkinson's Disease: A Prospective Cohort Study
American Journal of Epidemiology, 2007, 166, 1186-1190
2.464Citations (PDF)
311Prospective study of dietary pattern and risk of Parkinson disease
American Journal of Clinical Nutrition, 2007, 86, 1486-1494
3.2339Citations (PDF)
312Prospective case–control study of nonfatal cancer preceding the diagnosis of parkinson’s disease
Cancer Causes and Control, 2007, 18, 705-711
1.251Citations (PDF)
313ALS multidisciplinary clinic and survival
Journal of Neurology, 2007, 254, 1107-1112
2.769Citations (PDF)
314Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: A population-based study
Journal of the Neurological Sciences, 2006, 250, 45-49
1.292Citations (PDF)
315The epidemiology of ALS and the role of population-based registries
Biochimica Et Biophysica Acta - Molecular Basis of Disease, 2006, 1762, 1150-1157
2.8175Citations (PDF)
316Association of depression with Alzheimer's disease and vascular dementia in an elderly Arab population of Wadi‐Ara, Israel
International Journal of Geriatric Psychiatry, 2006, 21, 246-251
1.424Citations (PDF)
317Blood donations, iron stores, and risk of Parkinson's disease
Movement Disorders, 2006, 21, 835-838
3.237Citations (PDF)
318Migraine and Risk of Cardiovascular Disease in Women
JAMA - Journal of the American Medical Association, 2006, 296, 283
14.4511Citations (PDF)
319A clinical score for prognosis of status epilepticus in adults
Neurology, 2006, 66, 1736-1738
0.7225Citations (PDF)
320Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation
Journal of Neurology, Neurosurgery and Psychiatry, 2006, 77, 611-615
4.2304Citations (PDF)
321Physical activity and risk of Parkinson's disease: a prospective cohort study
Journal of Neurology, Neurosurgery and Psychiatry, 2006, 77, 1318-1322
4.295Citations (PDF)
322Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease
Neurology, 2006, 66, 1097-1099
0.7139Citations (PDF)
323Methodologic Issues in Studies of Mortality Following Epilepsy: Measures, Types of Studies, Sources of Cases, Cohort Effects, and Competing Risks
Epilepsia, 2005, 46, 3-7
3.040Citations (PDF)
324Epilepsy and Mortality in Africa: A Review of the Literature
Epilepsia, 2005, 46, 33-35
3.097Citations (PDF)
325Mortality after a First Episode of Status Epilepticus in the United States and Europe
Epilepsia, 2005, 46, 46-48
3.0173Citations (PDF)
326Classification of amyotrophic lateral sclerosis cases at presentation in epidemiological studies
Neurological Sciences, 2005, 26, 330-333
1.17Citations (PDF)
327Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study
Journal of Neurology, Neurosurgery and Psychiatry, 2005, 76, 1094-1098
4.2172Citations (PDF)
328The Role of Early Life Environmental Risk Factors in Parkinson Disease: What Is the Evidence?
Environmental Health Perspectives, 2005, 113, 1234-1238
5.8129Citations (PDF)
329Neuroepidemiology: From Principles to Practice
American Journal of Epidemiology, 2005, 161, 501-502
2.41Citations (PDF)
330Cigarette smoking and the progression of multiple sclerosis
Brain, 2005, 128, 1461-1465
5.9260Citations (PDF)
331Refractory Status Epilepticus
Archives of Neurology, 2005, 62, 1698
6.8391Citations (PDF)
332Apolipoprotein E, cardiovascular disease and cognitive function in aging women
Neurobiology of Aging, 2005, 26, 475-484
2.465Citations (PDF)
333Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years
BMJ: British Medical Journal, 2004, 328, 548
0.1170Citations (PDF)
334Folate Intake and Risk of Parkinson's Disease
American Journal of Epidemiology, 2004, 160, 368-375
2.471Citations (PDF)
335A prospective study of alcoholism and the risk of Parkinson?s disease
Journal of Neurology, 2004, 251, vii14-vii17
2.745Citations (PDF)
336Fructosamine, glycated hemoglobin, and dietary carbohydrates
Clinica Chimica Acta, 2004, 340, 139-147
0.723Citations (PDF)
337Apolipoprotein E genotype does not influence the progression of multiple sclerosis
Journal of Neurology, 2003, 250, 1094-1098
2.744Citations (PDF)
338Seborrheic dermatitis, increased sebum excretion, and Parkinson’s disease: a survey of (im)possible links
Medical Hypotheses, 2003, 60, 907-911
0.552Citations (PDF)
339Long-term mortality after a first episode of status epilepticus
Neurology, 2002, 58, 537-541
0.7217Citations (PDF)
340Treatment of Nonfebrile Status Epilepticus in Rochester, Minn, From 1965 Through 1984
Mayo Clinic Proceedings, 2001, 76, 39-41
1.931Citations (PDF)
341Time Trends in Incidence, Mortality, and Case-Fatality after First Episode of Status Epilepticus
Epilepsia, 2001, 42, 1031-1035
3.0106Citations (PDF)
342Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2001, 2, 99-104
1.533Citations (PDF)
343Morbidity of Nonfebrile Status Epilepticus in Rochester, Minnesota, 1965-1984
Epilepsia, 1998, 39, 829-832
3.041Citations (PDF)
344Risk of unprovoked seizure after acute symptomatic seizure: Effect of status epilepticus
Annals of Neurology, 1998, 44, 908-912
4.6270Citations (PDF)
345Environmental risk factors for Parkinson's disease in an urban multiethnic community
Neurology, 1998, 50, 279-281
0.757Citations (PDF)
346Incidence of status epilepticus in Rochester, Minnesota, 1965-1984
Neurology, 1998, 50, 735-741
0.7453Citations (PDF)
347Systemic iron metabolism and mortality from Parkinson's disease
Neurology, 1998, 50, 1138-1140
0.714Citations (PDF)
348Altered systemic iron metabolism in Parkinson's disease
Neurology, 1997, 49, 714-717
0.7121Citations (PDF)
349An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia
Neurology, 1997, 49, 30-37
0.7207Citations (PDF)
3502-17-07 Does status epilepticus increase the risk of death?
Journal of the Neurological Sciences, 1997, 150, S97
1.20Citations (PDF)
351Short‐Term Mortality After a First Episode of Status Epilepticus
Epilepsia, 1997, 38, 1344-1349
3.0306Citations (PDF)
352Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study
Annals of Neurology, 1996, 39, 89-94
4.6274Citations (PDF)
353Blood-cerebrospinal fluid barrier permeability to serum IgG subfractions and measurement of intrathecal IgG synthesis
Journal of the Neurological Sciences, 1986, 73, 325-338
1.21Citations (PDF)
354Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients
Journal of the Neurological Sciences, 1984, 64, 245-258
1.224Citations (PDF)
355Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
International Journal of Epidemiology, 0, , dyw061
2.8248Citations (PDF)
356Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia
Annals of Clinical and Translational Neurology, 0, 12, 1743-1752
2.35Citations (PDF)
357Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area
Current Opinion in Neurology, 0, 38, 588-595
2.42Citations (PDF)
358Incidence and Prevalence of Frontotemporal Dementia
JAMA Neurology, 0, 82, 1144
12.131Citations (PDF)
359Diffusion Models for Neuroimaging Data Augmentation: Assessing Realism and Clinical Relevance
Journal of Medical Systems, 0, 49,
3.43Citations (PDF)
360MRI ‐ DTI Biomarkers Along the Continuum of Behavioral Variant Frontotemporal Dementia
European Journal of Neurology, 0, 32,
2.41Citations (PDF)
361Prevention of dementia based on potential impact fraction: An analysis using global health databases
Journal of the Neurological Sciences, 0, 480, 124003
1.20Citations (PDF)
362Worldwide population attributable fraction of potentially modifiable risk factors for dementia: An analysis using global health databases
Journal of the Neurological Sciences, 0, 480, 124828
1.20Citations (PDF)
363Association between poor oral health and subjective cognitive decline in the US population
Journal of the Neurological Sciences, 0, 480, 123930
1.20Citations (PDF)
364Dynamic Smoking Patterns and Risk of Parkinson Disease
Neurology, 0, 106,
0.71Citations (PDF)
365Accuracy of clinical diagnosis of behavioral variant frontotemporal dementia: A systematic review and meta‐analysis
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 0, 18,
1.50Citations (PDF)
366Psychiatric and Cognitive Features in Italian Women With the FMR1 Premutation: A Comprehensive Assessment Using SCID ‐5 and Standardized Cognitive Measures
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 0, 201, 406-419
0.81Citations (PDF)
367Mental health within ESG frameworks: a narrative and descriptive cross-national analysis
Frontiers in Public Health, 0, 14,
1.80Citations (PDF)
368Association between self-reported poor oral health and subjective cognitive decline: a cross-sectional analysis of US survey data
Alzheimer's Research and Therapy, 0, 18,
4.30Citations (PDF)
369Optimizing single-session CBT delivery in an 8-session longitudinal therapeutic assessment (FRAX-TA) for women with FMR1 Premutation
Frontiers in Molecular Neuroscience, 0, 19,
2.40Citations (PDF)
370Incidence of primary progressive aphasia in Salento, Italy: a population-based study
Alzheimer's Research and Therapy, 0, 18,
4.30Citations (PDF)
371Behavioral and Personality Changes as the First Manifestation of Spinocerebellar Ataxia Type 2
Cerebellum, 0, 25,
1.90Citations (PDF)
372Neurofilament light and GFAP predict survival in frontotemporal dementia spectrum: A population-based study
Neurobiology of Disease, 0, 225, 107421
3.51Citations (PDF)
373Incidence and Prevalence of Dementia With Lewy Bodies
JAMA Neurology, 0, 83, 685
12.12Citations (PDF)
374Problematic Internet Use in Frontotemporal Dementia: A Case Series
Annals of Clinical and Translational Neurology, 0, ,
2.30Citations (PDF)
375Handgrip strength and relationship with non-motor symptoms in Parkinson's disease
Journal of Parkinson's Disease, 0, 16, 939-946
2.20Citations (PDF)
376Unraveling sleep dysfunction in progressive supranuclear palsy: a pilot study on the role of periodic limb movements in sleep and insomnia
Neurological Sciences, 0, 47,
1.10Citations (PDF)
377Association of hypoxic burden with brain atrophy in Alzheimer's disease
Journal of the Neurological Sciences, 0, 489, 126088
1.20Citations (PDF)
378Burden of Dementia in Europe, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023
Lancet Regional Health - Europe, The, 0, 68, 101796
5.60Citations (PDF)
379The Worldwide Burden of Parkinson's Disease Is Growing, but Its Incidence Is Not: Lessons from Population‐Based Studies
Movement Disorders, 0, ,
3.20Citations (PDF)